Indonesia approves China's Sinovac COVID-19 vaccine for kids aged 6-11 years

2021-11-01 08:55:36

Asian Tech Press (Nov 1) -- Indonesia has approved China's Sinovac COVID-19 vaccine for use in children aged 6-11 years.

Indonesia's drug and food agency (BPOM) said on Monday that the country approved Coronavac, the COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech Ltd (SVA: NASDAQ GS), for use in kids aged 6-11, Reuters reported.

Previously, Indonesia licensed the Sinovac vaccine for use in those aged 12 and above.

The approval was "pleasant news", said Penny K. Lukito, head of BPOM, at a press conference, according to the report.

Lukito said, "We're sure that children's vaccination is an urgent thing, especially now that…in-person learning has started."

Indonesia Sinovac Vaccine COVID

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tencent Holdings repurchased 3.93 million shares for HK$1.5 billion on January 7
                            2025-01-07

                                    Ireland recorded a 12.8 billion euro fiscal surplus last year due to the "Apple tax" ruling
                            2025-01-07

                                    Ministry of Industry and Information Technology: Promoting technical verification of 10G optical network and artificial intelligence integration
                            2025-01-07

                                    Tencent's major shareholder Prosus reduced its stake in Tencent Holdings from 24.01% to 23.99% on January 6.
                            2025-01-07

                                    U.S. chip stocks rose before the market opened, with Nvidia up 0.6%
                            2025-01-07